Susceptibility of Shigella species to erythromycin.
AUTOR(ES)
Greenberg, R N
RESUMO
Two of the most common causes of inflammatory enteritis are Campylobacter fetus subsp. jejuni and Shigella species. No single antimicrobial agent is recommended for treatment of both diseases. Erythromycin is used to treat C. fetus subsp. jejuni infections but has not been studied in shigellosis. For this reason, we determined the susceptibility of 22 strains of Shigella to erythromycin and found that Shigella species are susceptible to concentrations of erythromycin which are obtainable in stool.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181887Documentos Relacionados
- Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
- Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.
- Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.
- In vivo response of acute Q fever to erythromycin.
- Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.
